Kapanen A - Search Results

1

Effect of metal alloy surface stresses on the viability of ROS-17/2.8 osteoblastic cells.

Kapanen A, Danilov A, Lehenkari P, Ryhänen J, Jämsä T, Tuukkanen J. Kapanen A, et al. Biomaterials. 2002 Sep;23(17):3733-40. doi: 10.1016/s0142-9612(02)00107-2. Biomaterials. 2002. PMID: 12109698

2

TGF-beta1 secretion of ROS-17/2.8 cultures on NiTi implant material.

Kapanen A, Kinnunen A, Ryhänen J, Tuukkanen J. Kapanen A, et al. Biomaterials. 2002 Aug;23(16):3341-6. doi: 10.1016/s0142-9612(02)00023-6. Biomaterials. 2002. PMID: 12099276

3

Behaviour of nitinol in osteoblast-like ROS-17 cell cultures.

Kapanen A, Ilvesaro J, Danilov A, Ryhänen J, Lehenkari P, Tuukkanen J. Kapanen A, et al. Biomaterials. 2002 Feb;23(3):645-50. doi: 10.1016/s0142-9612(01)00143-0. Biomaterials. 2002. PMID: 11771684

4

Effect of nickel-titanium shape memory metal alloy on bone formation.

Kapanen A, Ryhänen J, Danilov A, Tuukkanen J. Kapanen A, et al. Biomaterials. 2001 Sep;22(18):2475-80. doi: 10.1016/s0142-9612(00)00435-x. Biomaterials. 2001. PMID: 11516078

5

Bone morphogenetic protein 3b expressing reindeer antler.

Kapanen A, Ryhänen J, Birr E, Väänänen HK, Tuukkanen J. Kapanen A, et al. J Biomed Mater Res. 2002 Jan;59(1):78-83. doi: 10.1002/jbm.1219. J Biomed Mater Res. 2002. PMID: 11745540

6

Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture.

Qu Q, Perälä-Heape M, Kapanen A, Dahllund J, Salo J, Väänänen HK, Härkönen P. Qu Q, et al. Among authors: kapanen a. Bone. 1998 Mar;22(3):201-9. doi: 10.1016/s8756-3282(97)00276-7. Bone. 1998. PMID: 9514212

7

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

Tanner M, Hollmén M, Junttila TT, Kapanen AI, Tommola S, Soini Y, Helin H, Salo J, Joensuu H, Sihvo E, Elenius K, Isola J. Tanner M, et al. Among authors: kapanen ai. Ann Oncol. 2005 Feb;16(2):273-8. doi: 10.1093/annonc/mdi064. Ann Oncol. 2005. PMID: 15668283 Free article.

8

Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer.

Tanner M, Kapanen AI, Junttila T, Raheem O, Grenman S, Elo J, Elenius K, Isola J. Tanner M, et al. Mol Cancer Ther. 2004 Dec;3(12):1585-92. Mol Cancer Ther. 2004. PMID: 15634652

9

Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance.

Barok M, Isola J, Pályi-Krekk Z, Nagy P, Juhász I, Vereb G, Kauraniemi P, Kapanen A, Tanner M, Vereb G, Szöllösi J. Barok M, et al. Among authors: kapanen a. Mol Cancer Ther. 2007 Jul;6(7):2065-72. doi: 10.1158/1535-7163.MCT-06-0766. Mol Cancer Ther. 2007. PMID: 17620435

10

Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line.

Nagy P, Friedländer E, Tanner M, Kapanen AI, Carraway KL, Isola J, Jovin TM. Nagy P, et al. Cancer Res. 2005 Jan 15;65(2):473-82. Cancer Res. 2005. PMID: 15695389

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters